Precancerous Conditions D011230

Diseases [C] » Neoplasms [C04] » Precancerous Conditions

Description

Pathological conditions that tend eventually to become malignant.   MeSH

Hierarchy View

Subtype Terms (10)

Aberrant Crypt Foci
2 drugs (1 approved, 1 experimental)

Barrett Esophagus
36 drugs (24 approved, 12 experimental)

Erythroplasia
 

Keratosis, Actinic
69 drugs (32 approved, 37 experimental)

Leukoplakia
3 approved drugs

Lymphomatoid Granulomatosis
82 drugs (54 approved, 28 experimental)

Preleukemia
10 drugs (7 approved, 3 experimental)

Smoldering Multiple Myeloma
31 drugs (19 approved, 12 experimental)

Uterine Cervical Dysplasia
21 drugs (10 approved, 11 experimental)

Xeroderma Pigmentosum
3 approved drugs



Organization Involved with Phase 2 Indications (54)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.